GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hodayat Haaretz Ltd (XTAE:HDHA-M) » Definitions » Asset Impairment Charge

Hodayat Haaretz (XTAE:HDHA-M) Asset Impairment Charge : ₪0.00 Mil (TTM As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is Hodayat Haaretz Asset Impairment Charge?

Hodayat Haaretz's Asset Impairment Charge for the six months ended in . 20 was ₪0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was ₪0.00 Mil.


Hodayat Haaretz Asset Impairment Charge Historical Data

The historical data trend for Hodayat Haaretz's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hodayat Haaretz Asset Impairment Charge Chart

Hodayat Haaretz Annual Data
Trend
Asset Impairment Charge

Hodayat Haaretz Semi-Annual Data
Asset Impairment Charge

Hodayat Haaretz Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was ₪0.00 Mil.


Hodayat Haaretz Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Hodayat Haaretz's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


Hodayat Haaretz Business Description

Traded in Other Exchanges
N/A
Address
7 Haarad Street, Tel-Aviv, ISR, 6971060
Hodayat Haaretz Ltd formerly Envizion Medical Ltd is a medical device company. It is focused on improving patient outcomes across the continuum of care, encompassing the development of advanced, personalized navigation technology for feeding tubes, responding to the challenges of the ever changing healthcare environment, while continuously focusing on the customer.

Hodayat Haaretz Headlines

No Headlines